Skip to main content
. 2019 Mar 12;10:146. doi: 10.3389/fendo.2019.00146

Figure 3.

Figure 3

Progression-free survival (PFS) by Kaplan-Meier analysis and log-rank test based on the presence of distant metastases at therapeutic 131I whole body scan (WBS) (A) complete response at 12 months evaluation after 131I therapy (B) complete response + partial response at 12 months evaluation after 131I therapy (C). t-WBS, therapeutic 131I WBS; DM, distant metastases; CR, complete remission; PR, partial remission.